Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ribaud

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|May 21, 2014
Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCTA Xhaard, H Moins-Teisserenc, M Busson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisationJ L Misset, G Mathé, M Tubiana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 1999
Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantationP Ribaud, C Chastang, J P Latgé, et al.
La Nouvelle Presse Medicale|January 9, 1982
[Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]G Mathé, R de Jager, R Hulhoven, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorizationJ L Misset, G Mathé, M Tubiana, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomasM Bayssas, J Gouveia, P Ribaud, et al.
Experimental Hematology|November 8, 2001
Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplantsV Rocha, M V Carmagnat, S Chevret, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1982
Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNUG Mathe, P Schein, J S MacDonald, et al.
Bone Marrow Transplantation|April 25, 2001
Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemiaR Morariu-Zamfir, V Rocha, A Devergie, et al.
Leukemia|November 14, 2008
Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemiaV Rocha, R Porcher, J F Fernandes, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|May 21, 2014
Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCTA Xhaard, H Moins-Teisserenc, M Busson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisationJ L Misset, G Mathé, M Tubiana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 1999
Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantationP Ribaud, C Chastang, J P Latgé, et al.
La Nouvelle Presse Medicale|January 9, 1982
[Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]G Mathé, R de Jager, R Hulhoven, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorizationJ L Misset, G Mathé, M Tubiana, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomasM Bayssas, J Gouveia, P Ribaud, et al.
Experimental Hematology|November 8, 2001
Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplantsV Rocha, M V Carmagnat, S Chevret, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1982
Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNUG Mathe, P Schein, J S MacDonald, et al.
Bone Marrow Transplantation|April 25, 2001
Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemiaR Morariu-Zamfir, V Rocha, A Devergie, et al.
Leukemia|November 14, 2008
Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemiaV Rocha, R Porcher, J F Fernandes, et al.
Pageof 14